3 ASX Growth Companies With Up To 15% Insider Ownership
As the Australian market opens with a modestly positive outlook, influenced by Wall Street's tech-driven gains and ongoing discussions around interest rates, investors are keenly watching how local technology stocks respond amidst broader economic uncertainties. In this environment, growth companies with high insider ownership can offer unique insights into potential long-term value creation, as insiders typically have a vested interest in the company's success and may provide stability amid fluctuating market conditions.
Top 10 Growth Companies With High Insider Ownership In Australia
| Name | Insider Ownership | Earnings Growth |
| Wisr (ASX:WZR) | 10.3% | 94.2% |
| Starpharma Holdings (ASX:SPL) | 19.3% | 92% |
| SKS Technologies Group (ASX:SKS) | 19.3% | 27.7% |
| Pure One (ASX:P1E) | 11.3% | 78.2% |
| PDI Gold (ASX:PDI) | 10.4% | 63.6% |
| Forrestania Resources (ASX:FRS) | 24.7% | 72.9% |
| DXN (ASX:DXN) | 13.5% | 129.3% |
| Austral Resources Australia (ASX:AR1) | 24% | 28.2% |
| Adveritas (ASX:AV1) | 17.6% | 99.9% |
| Advanced Engineered Materials (ASX:AEM) | 35.1% | 58.7% |
Let's explore several standout options from the results in the screener.
Artrya (ASX:AYA)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Artrya Limited is a medical technology company focused on developing and commercializing an artificial intelligence platform for detecting, diagnosing, and addressing coronary artery disease in Australia, with a market cap of A$630.67 million.
Operations: The company generates revenue from its AI-driven CCTA image analysis technology, amounting to A$0.03 million.
Insider Ownership: 10.8%
Artrya is experiencing significant revenue growth, forecasted at 48.5% annually, outpacing the Australian market's average. Despite current low revenue of A$28K and a net loss of A$25.18 million for the year ended June 2026, it is expected to become profitable within three years. Recent additions to major indices like S&P/ASX 300 highlight its growing recognition. The appointment of Helen Kurincic as a Non-Executive Director strengthens its leadership with her extensive industry experience.
- Click to explore a detailed breakdown of our findings in Artrya's earnings growth report.
- Our valuation report unveils the possibility Artrya's shares may be trading at a premium.
Cobram Estate Olives (ASX:CBO)
Simply Wall St Growth Rating: ★★★★★☆
Overview: Cobram Estate Olives Limited is an olive oil producer and marketer operating in Australia, the United States, and internationally with a market cap of A$1.38 billion.
Operations: The company's revenue segments consist of Olive Oil and Other Packaged Goods from its USA Operations, generating A$95.01 million, and Australian Operations, contributing A$180.09 million.
Insider Ownership: 13.1%
Cobram Estate Olives is forecasted to achieve significant revenue growth of 24.2% annually, surpassing the Australian market average. Despite reporting a net loss of A$4.23 million for the year ending June 2026, it is expected to become profitable within three years. Insider confidence remains strong with substantial share purchases and no major sales in recent months. The company's inclusion in the S&P Global BMI Index underscores its increasing market presence and potential for future growth.
- Click here and access our complete growth analysis report to understand the dynamics of Cobram Estate Olives.
- The analysis detailed in our Cobram Estate Olives valuation report hints at an inflated share price compared to its estimated value.
Magellan Financial Group (ASX:MFG)
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Magellan Financial Group Limited is a publicly owned investment manager with a market cap of A$2.44 billion.
Operations: The company's revenue segments include Corporate at A$5.02 million, Partnerships & Investments at A$40.10 million, and Investment Management Services at A$205.69 million.
Insider Ownership: 15.5%
Magellan Financial Group is experiencing a period of transition with new leadership, including CEO Brian Benari and Chairman David Gonski. Despite being dropped from the FTSE All-World Index, its revenue is expected to grow at 20.7% annually, outpacing the Australian market. However, recent earnings have declined to A$87.92 million from A$165.02 million last year, and dividends remain unsustainable at 7.79%. Insider buying has occurred but not in substantial volumes recently.
- Take a closer look at Magellan Financial Group's potential here in our earnings growth report.
- Our expertly prepared valuation report Magellan Financial Group implies its share price may be too high.
Key Takeaways
- Click through to start exploring the rest of the 112 Fast Growing ASX Companies With High Insider Ownership now.
- Contemplating Other Strategies? This technology could replace computers: discover the 25 stocks are working to make quantum computing a reality.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com